ir.sparktx.com
Business-Class Web Hosting by (mt) Media TempleCategory: Internet, This is an automatically generated default server page successfully deployed by (mt) Media Temple web hosting.
http://ir.sparktx.com/
Category: Internet, This is an automatically generated default server page successfully deployed by (mt) Media Temple web hosting.
http://ir.sparktx.com/
TODAY'S RATING
>1,000,000
Date Range
HIGHEST TRAFFIC ON
Wednesday
LOAD TIME
1.1 seconds
PAGES IN
THIS WEBSITE
0
SSL
EXTERNAL LINKS
11
SITE IP
216.70.114.41
LOAD TIME
1.094 sec
SCORE
6.2
Business-Class Web Hosting by (mt) Media Temple | ir.sparktx.com Reviews
https://ir.sparktx.com
Category: Internet, This is an automatically generated default server page successfully deployed by (mt) Media Temple web hosting.
Careers | Spark Therapeutics
http://www.sparktx.com/careers
Skip to main content. Spark was founded on a legacy of scientific excellence and unwavering dedication to patients, and to that foundation we are establishing a culture of integrity, transparency and collaboration, instilling a collective sense of urgency on behalf of patients and ownership in our company’s success. Jeffrey D. Marrazzo, Co-Founder and CEO.
Pipeline | Spark Therapeutics
http://www.sparktx.com/pipeline
Skip to main content. We are working to address a range of debilitating genetic diseases including inherited retinal diseases, hematologic disorders and neurodegenerative diseases. Our most advanced product candidate,. Is in a fully-enrolled pivotal Phase 3 clinical trial for the treatment of inherited retinal diseases (IRDs) caused by mutations in the RPE65 gene. Has orphan designation in the United States (U.S.) and the European Union, and breakthrough therapy designation in the U.S. Or by calling 1-85...
Integrated Platform | Spark Therapeutics
http://www.sparktx.com/integrated-platform
Skip to main content. Spark's integrated gene therapy platform is accelerating the development of product candidates for a range of debilitating genetic diseases. Our integrated gene therapy platform builds on two decades of translational research, clinical development, regulatory affairs and manufacturing expertise at The Children's Hospital of Philadelphia, including human trials conducted across diverse therapeutic areas and routes of administration.
About Spark | Spark Therapeutics
http://www.sparktx.com/about-spark
Skip to main content. Spark Therapeutics is developing potential one-time, life-altering gene therapies to transform the lives of patients and re-imagine the treatment of debilitating diseases. Our most advanced product candidate,. Is intended to treat rare blinding conditions caused by mutations in the. Gene In October 2015, we announced. Positive top-line results from the Phase 3 pivotal trial of. In the first randomized controlled Phase 3 trial of a gene therapy for genetic disease, we found that subj...
Leadership Team | Spark Therapeutics
http://www.sparktx.com/pioneering-leadership
Skip to main content. Our team includes world leaders in the research, development and manufacture of gene therapies, as well as seasoned commercial, entrepreneurial and executive management. Jeffrey D. Marrazzo. Co-Founder and Chief Executive Officer. Katherine A. High, M.D. Co-Founder, President and Chief Scientific Officer. Rogério Vivaldi, M.D. From Dartmouth College and his M.B.A. in finance from the Wharton School at the University of Pennsylvania. Daniel R. Faga. J Fraser Wright, Ph.D.
Spark Therapeutics
http://twin-imagesv2.hiringhook.com/jobseeker/profile.aspx
Skip to main content. Please take a few moments to provide some information about yourself. First Name and Middle Initial. Please provide an email address. You already have a profile. Sign in here. San Tome and Principe. St Pierre and Miquelon. St Vincent and the Grinadines. Turks and Caicos Islands. United States Virgin Islands. Wallis and Futuna Islands. Degree Type 1 *. Are you currently employed? Current / Most Recent Position Title. Use ctrl click to select multiple).
TOTAL LINKS TO THIS WEBSITE
11
Sonae Sierra - Investor Relations
My Downloads ( 0 ). History and Corporate Profile. Strategy and Competitive Advantages. Shopping Center Sector Regulation. Management and Board of Directors. Notice to the Market. Presentations and Conference Calls. To configure "My favorites" Click on Configure or click on the icon. In the toolbar below the title. To exclude it, just click on. Select your favorite channels below clicking on the star icon. History and Corporate Profile. Strategy and Competitive Advantages. Notice to the Market.
Investor Relations - Sonic Corp.
Drive Into Your Future. Where We’re Going. Drive Into Your Future. For more than 50 years, SONIC Corp. has built a dominant position in the drive-in restaurant business. We did it by sticking to what made drive-ins so popular in the first place: made-to-order American classics, signature menu items, speedy service from friendly Carhops and heaping helpings of fun and personality. Mar 27, 2018 at 5:00 PM ET. Second Quarter 2018 Release and Conference Call. Jan 8, 2018 at 2:00 PM ET. Mar 27, 2018.
Portable, Point-of-Care Ultrasound | SonoSite
Contact us by Email. Or call 1.877.290.4911. Conferences and Society Meetings. From Skeptic To Believer. Ultrasound Guided Peripheral IV's. 97% First-Pass Success For CVC Placement. Score Zero CLABSI in ICU. Preventative Screenings Impact Lives. Transforming a health system. Videos: MSK Ultrasound Tech. For Dealers and Support Staff. Learn how to improve clinical. Outcomes while reducing costs. Remote Healthcare: 6 Episode Series. Remote Healthcare: 6 Episode Series. DOWNLOAD THE NEW SONOACCESS. Pneumoth...
Soul and Vibe Interactive | Investors | Overview
Follow Soul and Vibe. Publicly Traded OTCQB: SOUL. Soul and Vibe Interactive Inc. (OTCQB: SOUL). And game development and publishing agreements for the Xbox 360. Video game and entertainment system, Windows 8, Windows Live, and Windows Phone from Microsoft. And the PlayStation 3 computer entertainment system and PlayStation Vita (PS Vita) from Sony. Soul and Vibe Interactive Inc. 1660 South Hwy 100. St Louis Park, MN 55416. Soul and Vibe Releases "Smorgon Magma, The Black Rider" Multi-Track Music Single.
ir.space.lc
Business-Class Web Hosting by (mt) Media Temple
Mt) Media Temple,Inc. - Web Hosting Built to Scale. This page has been generated automatically. If you are the server administrator and you feel that you have reached this page in error, then try completing the following steps. Please consult the (mt) KnowledgeBase. Articles below for more information. 1 Log in to Plesk ». 2 Make sure domain is added ». 3 Create your subscription ». View all related articles ». 24-7 Global Support - 877-578-4000. 1998-2012 (mt) Media Temple, Inc. Legal.
История революций. Социалистические революции (во всём мире). Красное движение. Лидеры и идеология
Энциклопедия коммунизма. Социалистические революции. Template ."/tools.php");? Революция по Джину Шарпу. Джин Шарп известен узкому кругу посвящённых людей. Распад СССР, революция в Бирме, бархатная революция в Чехословакии, акции протеста в Тибете, Таиланде, на Ближнем Востоке и Сербии, несколько цветных революций в постсоветских странах, всё это происходило с использованием разработанных Шарпом технологий. Что лучше капитализм или коммунизм? Исландия, уроки кризиса. Социалистические революции в мире:.
Spherix | Spherix
15879 N. 80th Street. Scottsdale, AZ 85260. Spherix seeks to enhance shareholder value not only through exceptional business performance and practices, but also through responsible and effective communication with its shareholders. The latest company information relevant to the individual and institutional investor includes stock price and history, upcoming events and presentations and financial documents. Spherix is traded on the NASDAQ under the ticker symbol SPEX. MOST RECENT FINANCIAL RESULTS.
Login
Need help logging in? Please call 00 44 (0)844 238 0032 or email css@spicers.co.uk. 169; SPICERS 2015.
Investor Relations - Spirit Airlines, Inc.
Stock Quote and Chart. Annual Reports and Proxies. Traffic Releases and Investor Updates. Financial and Operating Stats Database. Q1 2018 Earnings Call. Apr 26, 2018 at 9:30 AM ET. Raymond James 39th Annual Institutional Investors Conference. Mar 6, 2018 at 4:00 PM ET. Q4 2017 Earnings Call. Feb 6, 2018 at 9:00 AM ET. 079 ( 2.14%). Delayed at least 20 minutes. Most Recent Earnings Release. February 6, 2018. March 6, 2018. February 6, 2018. March 1, 2018. Sr Director, Investor Relations. Sign up for alerts.
Investor Overview - Investors & Media - Spring Bank Pharmaceuticals
Mission and Business Strategy. Mission and Business Strategy. January 2017 Corporate Presentation. Spring Bank is a clinical-stage biopharmaceutical company engaged in the discovery and development of a novel class of therapeutics using its proprietary small molecule nucleic acid hybrid, or SMNH, chemistry platform. 160; 0.04. There are currently no events scheduled. Garrett Winslow Joins Spring Bank as Vice President of Legal. Spring Bank Pharmaceuticals Announces Financing of $15 Million. Proceeds to ...
